Objectives ⢠New drug approval process ⢠Pricing of new drugs ⢠Off ...
Objectives ⢠New drug approval process ⢠Pricing of new drugs ⢠Off ...
Objectives ⢠New drug approval process ⢠Pricing of new drugs ⢠Off ...
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
3/15/13%<br />
Prescription Drug User Fee Act V –<br />
effective Oct 1 st 2012<br />
• FDA pledges to review 90% <strong>of</strong> NDAs within<br />
12 months<br />
• Expectation is that this increases # <strong>of</strong> first<br />
cycle <strong>approval</strong>s<br />
• Mid cycle and late-cycle review meetings<br />
with sponsors<br />
• Increased communication & transparency<br />
• Pre-submission meeting to ensure NDA/BLA<br />
completeness<br />
• User fees increase:<br />
• Application now $ 1.96 million (6.3% inc)<br />
9%